Enzymatics T4 DNA Ligase（L6030HCL）超低价现货促销 产品资讯 资讯 蚂蚁淘在线

Enzymatics专注于于酶产品的研发，为市场带来了特殊的、高品质的产品。是一家试剂、试剂盒和测定的领先生产商，使全球客户变革了诊断、治疗和生命科学的研究。业务包括：试剂、供应链解决方案，应用科学。目前市场上80%测序产品来自Enzymatics（Todayourproductsunderpinover80%ofthesequencingreactionsthatarerunaroundtheglobe）。Enzymatics产品的好处之一--能提高效率：NatureMethods中提到使用Enzymatics超纯连接酶，连接步骤的效率得以提高，连接片段的产量增加了20-30%。好处之二--有效降低测序成本：遗传学界的泰斗GeorgeChurch更是认为Enzymatics是apowerfulcatalystinthedemocratizationofsequencing。合作伙伴包括：BGI，BerryGenomics，Illumina，454LifeSciences和IonTorrentSyst，皆对Enzymatics的出品赞不绝口。Enzymatics产品包括八类：超纯连接酶如T4连接酶、超纯poly酶、ArcherTM系列测序工具、连接蛋白、DNA修饰酶、NGS文库制备、核酸和RNA酶。Enzymatics公司之操作体系以严格著称，产品通过了ISO13485:2003和9001:2000体系标准认证，并符合FDA21CFR.820质量系统法规中对于常规用途试剂的生产规范。与此同时，Enzymatics的生产能力被许多FDA认证的医疗设备制造商以及国际著名的ISO认证机构TVSD认可。（http://www.enzymatics.com/）目前蚂蚁淘生物公司已成功取得Enzymatics中国总代理，Enzymatics各大产品均可在我司查询订购，咨询电话4006-400-850。

Enzymaticsisaleadingproducerofreagents,kits,andassaysthatenableourcustomersworldwidetotransformpatientdiagnosis,treatment,andlifescienceresearch.Ourbusinessunitsinclude:Reagents,SupplyChainSolutions,AppliedScience.

Ourpassionforquality,responsiveness,andflexibilityiscatalyzingthegenomichealthcarerevolution.

Enzymatics:CatalyzingtheGenomicsHealthcareRevolution

TheEnzymaticsstorystartsin2005whenStevePiconeandChrisBenoitwereproductionscientistsatamajormolecularbiologyreagentscompany.Theyrealizedthattherewasanemergingneedinthemarketforlargequantitiesofultra-highpurityenzymesproducedconsistently,underarigorousqualitysystem,andofferedforsaleataverylowpricepoint.Thetechnologydrivingthesedemandswashigh-throughputDNAsequencing,whichutilizesenzymestotranslateaDNAsequenceintosearchabledata.Atthattime,sequencingwashardlyhigh-throughputasitcostover$10Mandtookmonthstodecodethesequenceofasinglehumangenome.SteveandChrisrecognizedthepotentialofDNAsequencingtorevolutionizemedicine,andconcludedthattheycoulduniquelymeetthisnewsetofrequirementsanddrivedownthecostofsequencing.TheystartedEnzymaticswiththeexpresspurposeofeliminatingthecostofsequencingasabarriertoadoptionintheclinicalsetting.Theplantoachievethiswastofocusonhighquality,well-controlledproduction,thedevelopmentofaclinically-alignedqualitysystem,treatingeverycustomerasapartner,andredefiningthewaybywhichreagentsarepriced.

SignificantReductioninCostofSequencing

AtEnzymatics,westrivetoconstantlychallengethestatusquo.IfwelookatarecentanalysisdonebytheNationalInstitutesofHealthontheaveragepricetosequenceahumangenomeovertime,itisclearthatin2007,thecostofsequencingbegantodropprecipitously.Althoughthefactorsresponsibleforthisaccelerationtowardsaffordablesequencingarenumerous,Enzymaticswaspartofthattransformation.Infact,theheadofourscientificadvisoryboard,Dr.GeorgeChurch,athoughtleaderinsequencing,hasnotedthatEnzymaticshas,indeed,beenapowerfulcatalystinthedemocratizationofsequencing.

ANewErainHealthcare

Asaresultofthismassiveandcontinualreductioninthecostofsequencing,anentirelynewindustryhasemergedthatisleveragingthepowerofgeneticinformationtodiagnoseandtreathumandisease.Enzymaticshasbeenanenablingfactorinthebirthofthisnewsegmentofnucleicacid-baseddiagnostics,andweremainpassionatelycommittedtosupportingthecompanieswhosegenomictechnologieswillrevolutionizepersonalizedhealthcare.

CatalyzingtheGenomicHealthcareRevolution

In2006,whenEnzymaticsstarted,theconceptwastoenablebetter,faster,cheapersequencingbyfocusingonthedesignandproductionoftheworldsbestmolecularbiologyenzymes.Todayourproductsunderpinover80%ofthesequencingreactionsthatarerunaroundtheglobe,andwestilldobusinesswithnotonlyourveryfirstcustomer,butnearlyeveryothercompanywithwhomwevepartnered.